Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa

Haemophilia

Volumn 6, Issue 2, 2000, Pages 93-97

  Rubinstein, R ^a,b   Karabus, C D ^a   Smuts, H ^b   Kolia, F ^a   Van Rensburg, E J ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Haemophilia; Parvovirus B19; TTV

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTHROMBIN COMPLEX; VIRUS DNA;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TORQUE TENO VIRUS; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, VIRAL; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; DNA VIRUS INFECTIONS; DNA, VIRAL; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SOUTH AFRICA; TOPOGRAPHY, MEDICAL;

EID: 0034020503     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00371.x     Document Type: Article

References (23)

1. Mortimer PP, Luban NLC, Kelleher JF, Cohen BJ. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983; ii: 482-4.
2. Azzi A, Ciappi S, Zakvrezewska K, Morfini M, Marianni G, Mannucci PM. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 39: 228-30.
3. Williams MD, Cohen BJ, Beddall AC, Pasi KJ, Mortimer PP, Hill FGH. Transmission of human parvovirus B19 in coagulation factor concentrates. Vox Sanguinis 1990; 58: 177-81.
4. Santagostino E, Mannucci PM, Gringeri A et al. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 °C heat after lyophilization. Transfusion 1997; 37: 517-22.
5. Morfini M, Longo G, Rossi Ferrini P et al. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus. Am J Hematol 1992; 39: 149-50.
6. Rubinstein AI, Rubinstein DB, Coughlin J. Combined solvent/detergent and 100 °C (boiling) sterilizing dryheat treatment of factor VIII concentrates to assure sterility. Vox Sanguinis 1991; 60: 60 (letter).
7. Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407-12.
8. Hilfenhaus J, Groner A, Nowak T, Weimer T. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion 1997; 37: 935-40.
9. Nishizawa TH, Okamoto K, Konishi H, Yoshizawa Y, Miyakawa M. Mayumi A. A novel DNA virus (TTV) associated with elevated transaminase levels in post transfusion hepatitis of unknown origin. Biochem Biophys Res Commun 1997; 241: 92-7.
10. Fukuda Y, Nakano I, Katano Y et al. TT virus infection in Japanese haemophilia patients. Hepatology 1998; 28: 291A.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual 2nd edn. Philadelphia: Cold Spring Harbor Laboratory Press, 1989.
12. Lench N, Stanier P, Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet 1988; i: 1356-8.
13. Pattison JR, Jones SE, Hodgson J et al. Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet 1981; 1: 664-5.
14. Musiani M, Azzi A, Zerbini M et al. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol 1993; 40: 157-60.
15. Salimans MM, Holsappel S, van de Rijke FM, Jiwa NM, Raap AK, Weiland HT. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods 1989; 23: 19-28.
16. McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Micro 1993; 31: 323-8.
17. Lin K-H, You S-L, Chen C-J, Wang C-F, Yang C-S, Yamazaki S. Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 1999; 57: 169-73.
18. Yoto Y, Kudoh T, Haseyama K et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995; 91: 1017-8.
19. Luban NLC. Human parvovirus: implication for transfusion medicine. Transfusion 1994; 34: 821-7.
20. Bartolomei Corsi O, Azzi A, Morfini M, Fanci R, Rossi Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Vir 1988; 25: 165-70.
21. Simmonds P, Davidson F, Lycett C et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998; 352: 191-5.
22. Niel C, de Oliveira JM, Ross RS, Gomes SA, Roggendorf M, Viazov S. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 1999; 57: 259-63.
23. Schröter M, Feucht H-H, Schäfer P et al. TT virus viremia and liver transplantation: no significant increase of the prevalence. Blood 1998; 92: 4877-8.